beta
IA Trial Radar
O estudo clínico NCT07255131 (RAKITZIHCFA) para Depression - Major Depressive Disorder, Anxiety Chronic, Ansiedade, Desfecho funcional, Recuperação, Obsessive Compulsive Disorders, Assertiveness está recrutando. Consulte a visualização em cartões do Radar de Estudos Clínicos e as ferramentas de descoberta de IA para ver todos os detalhes. Ou pergunte qualquer coisa aqui.
Um estudo corresponde aos critérios do filtro
Visualização em cartões

The Effectiveness and Efficacy of an Online Cognitive Behavioral Psychotherapeutic Program (RAKITZIHCFA)

Recrutando
Os detalhes do estudo clínico estão disponíveis principalmente em inglês. No entanto, a IA Trial Radar pode ajudar! Basta clicar em 'Explicar o estudo' para visualizar e discutir as informações do estudo no idioma selecionado.
O estudo clínico NCT07255131 (RAKITZIHCFA) é um ensaio intervencionista para Depression - Major Depressive Disorder, Anxiety Chronic, Ansiedade, Desfecho funcional, Recuperação, Obsessive Compulsive Disorders, Assertiveness. Seu status atual é: recrutando. O estudo começou em 26 de setembro de 2025 e pretende incluir 52 participantes. Coordenado por Rakitzi, Stavroula e deve ser concluído em 20 de dezembro de 2028. Essas informações foram atualizadas no ClinicalTrials.gov em 28 de novembro de 2025.
Resumo
An online group cognitive behavioral psychotherapeutic program will be offered to patients with cystic fibrosis and to caregivers by the Hellenic Cystic Fibrosis Association. These 2 above therapy groups will be compared with control groups in a randomized controlled trial
Descrição detalhada
A therapy group of patients with cystic fibrosis, who participate on the online group cognitive behavioral psychotherapeutic program will be compared with a control group of patients with cystic fibrosis, who participate in an online group supportive psychotherapeutic program. Both of the groups participate on 13 sessions once a week.

A therapy group of caregivers, who participate on the online group cognitive behavioral psychotherapeutic program will be compared with a control group of caregivers, who participate in an online group supportive psychotherapeutic program. Both of the groups participate on 13 sessions once a week.

Título oficial

The Effectiveness and Efficacy of an Online Group Cognitive Behavioral Psychotherapy in Patients With Cystic Fibrosis and Caregivers in Comparison to Control Groups by the Hellenic Cystic Fibrosis Association A Randomized Controlled Trial

Condições
Depression - Major Depressive DisorderAnxiety ChronicAnsiedadeDesfecho funcionalRecuperaçãoObsessive Compulsive DisordersAssertiveness
Publicações
Artigos científicos e trabalhos de pesquisa publicados sobre este estudo clínico:
Outros IDs do estudo
  • RAKITZIHCFA
  • RAKITZI CYSTIC FIBROSIS
  • HELLENIC CYSTIC FIBROSIS ASSOC (Outro identificador) (HELLENIC CYSTIC FIBROSIS ASSOCIATION & DR. STAVROULA RAKITZI)
Número NCT
Data de início (real)
2025-09-26
Última atualização postada
2025-11-28
Data de conclusão (estimada)
2028-12-20
Inscrição (estimada)
52
Tipo de estudo
Intervencionista
FASE
N/A
Status
Recrutando
Palavras-chave
Cystic Fibrosis
Group cognitive behavioral psychotherapy
Propósito principal
Tratamento
Alocação do design
Randomizado
Modelo de intervenção
Atribuição paralela
Cegamento (Mascaramento)
Simples-cego
Braços / Intervenções
Grupo de participantes/BraçoIntervenção/Tratamento
ExperimentalTherapy group A patients with Cystic Fibrosis
Participation on an online group cognitive behavioral psychotherapy via Zoom in 13 sessions.
Group a an Online Group Cognitive Behavioral Psychotherapy in 13 Sessions Via Zoom
An online group cognitive behavioral psychotherapy will be offered via Zoom in 13 sessions to the therapy Group A, to patients with cystic fibrosis
Comparador ativoControl group B Patients with cystic fibrosis
Participation on an online group supportive psychotherapy via Zoom in 13 sessions.
Group B an Online Group Supportive Psychotherapy in 13 Sessions Via Zoom
An online group supportive psychotherapy will be offered via Zoom in 13 sessions to the control group Group B, to patients with cystic fibrosis
ExperimentalTherapy group C caregivers of patients with cystic fibrosis
Participation on an online group cognitive behavioral psychotherapy via Zoom in 13 sessions.
Group C an Online Group Cognitive Behavioral Psychotherapy in 13 Sessions Via Zoom
An online group cognitive behavioral psychotherapy will be offered via Zoom in 13 sessions to the therapy group C, to caregivers of patients with cystic fibrosis
Comparador ativoContol group D caregivers of patients with cystic fibrosis
Participation on an online group supportive psychotherapy via Zoom in 13 sessions.
Group D an Online Group Supportive Psychotherapy in 13 Sessions Via Zoom
An online group supportive psychotherapy will be offered via Zoom in 13 sessions to the control Group D, to caregivers of patients with cystic fibrosis
Desfecho primário
Medida de desfechoDescrição da medidaPrazo
SCL-90-R
It evaluates psychopathology. T\>60 means psychopathology. Low scores better
Preintervention
SCL-90-R
It evaluates psychopathology. T\>60 means psychopathology. Low scores better
Immediately after the intervention
SCL-90-R
It evaluates psychopathology. T\>60 means psychopathology. Low scores better
Follow-up up to 24 weeks
SRSDA
It measures Depression. Minimum 0 Maximum over 14. Low scores better
Preintervention
SRSDA
It measures Depression. Minimum 0 Maximum over 14. Low scores better
Immediately after intervention
SRSDA
It measures Depression. Minimum 0 Maximum over 14. Low scores better
Follow-up up to 24 weeks
SRSDA
It measures anxiety. Minimum 0 Maximum over 10. Low scores better
Preintervention
SRSDA
It measures anxiety. Minimum 0 Maximum over 10. Low scores better
Immediately after intervention
SRSDA
It measures anxiety. Minimum 0 Maximum over 10. Low scores better
Follow-up up to 24 weeks
U Uncertainty questionnaire
It evaluates social skills and assertiveness.: fear of criticism (psychopathology in \>35), fear of contact (psychopathology in \>41) , assertiveness (psychopathology in \<26) , difficulty of saying no (psychopathology in \>28) , guilt and decency (psychopathology in \>9)
Preintervention
U Uncertainty questionnaire
It evaluates social skills and assertiveness.: fear of criticism (psychopathology in \>35), fear of contact (psychopathology in \>41) , assertiveness (psychopathology in \<26) , difficulty of saying no (psychopathology in \>28) , guilt and decency (psychopathology in \>9)
Immediately after the intervention
U Uncertainty questionnaire
It evaluates social skills and assertiveness.: fear of criticism (psychopathology in \>35), fear of contact (psychopathology in \>41) , assertiveness (psychopathology in \<26) , difficulty of saying no (psychopathology in \>28) , guilt and decency (psychopathology in \>9)
Follow up up to 24 weeks
Hamilton Depression Scale
It measures depression. Minimum 0, maximum 23. Low scores better.
Preintervention
Hamilton Depression Scale
It measures depression. Minimum 0, maximum 23. Low scores better.
Immediately after the intervention
Hamilton Depression Scale
It measures depression. Minimum 0, maximum 23. Low scores better.
Follow up up to 24 weeks
WHODAS total
It measures functional outcome. Minimum 0, maximum 100. low scores better.
Preintervention
WHODAS total
It measures functional outcome. Minimum 0, maximum 100. low scores better.
Immediately after the intervention
WHODAS total
It measures functional outcome. Minimum 0, maximum 100. low scores better.
Follow up up to 24 weeks
RAS-DS total
Recovery. It measures recovery. Minimum 0, maximum 152. High scores better.
Preintervention
RAS-DS total
Recovery. It measures recovery. Minimum 0, maximum 152. High scores better.
Immediately after intervention
RAS-DS total
Recovery. It measures recovery. Minimum 0, maximum 152. High scores better.
Follow up up to 24 weeks
Critérios de elegibilidade

Idades elegíveis
Adulto, Adulto mais velho
Idade mínima
18 Years
Sexos elegíveis
Todos
  • Age 18-70
  • Members of the Hellenic Cystic Fibrosis Association
  • Willingness to participate on 13 sessions via Zoom

  • Age over 70
  • Not members of the Hellenic Cystic Fibrosis Association
  • Not able to participate on 13 sessions via Zoom
Rakitzi, Stavroula logoRakitzi, Stavroula
Responsável pelo estudo
Dr. Stavroula Rakitzi, Investigador principal, PhD, Clinical psychologist and cognitive behavioral psychotherapist, Rakitzi, Stavroula
Contato central do estudo
Contato: Dr. Stavroula Rakitzi, PhD, +306989766935, [email protected]
Contato: Mrs Anna Spinou, President of the Hellenic Cystic Fibrosis Association, Msc, +306944255853, [email protected]
1 Locais do estudo em 1 países
Private practice, ILISION 34 15771 Athens Greece, Athens, 15771, Greece
Dr. Stavroula Rakitzi, PhD, Contato, +306989766935, [email protected]
Mrs Anna Spinou, President of the Hellenic Cystic Fibrosis Association, Msc, Contato, +306944255853, [email protected]
Recrutando